towards a personalized treatment approach for scd
Published 2 years ago • 100 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
3:25
personalizing therapy in aml: current status and future outlooks
-
0:59
hdxsim: a clinical decision support tool for model-informed precision dosing of hydroxyurea in scd
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
3:15
how novel agents are transforming the treatment landscape of scd
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:56
personalizing cll therapy in the frontline
-
2:16
current and future treatment approaches for hr-mds
-
3:16
improving upon the standard of care for patients with richter’s transformation
-
1:12
an update in cellular therapies: gene editing for scd and immunotherapies for mm
-
2:13
haploidentical sct for the treatment of secondary aml
-
2:12
the regulation of personalized medicine trials
-
1:03
personalizing aml treatment by targeting mrd mutations
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:03
the current landscape of treatment for bpdcn